{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ACER",
        "Security_Name": "Acer Therapeutics Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "S",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ACER",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 1,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 0,
                "buy": 3,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 3,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 2,
                "hold": 2,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 2.81,
        "open": 2.8,
        "dayLow": 2.76,
        "dayHigh": 2.885,
        "regularMarketPreviousClose": 2.81,
        "regularMarketOpen": 2.8,
        "regularMarketDayLow": 2.76,
        "regularMarketDayHigh": 2.885,
        "payoutRatio": 0,
        "beta": 1.202586,
        "forwardPE": -4.5737705,
        "volume": 276759,
        "regularMarketVolume": 276759,
        "averageVolume": 478380,
        "averageVolume10days": 991580,
        "averageDailyVolume10Day": 991580,
        "bid": 2.75,
        "ask": 3,
        "bidSize": 1000,
        "askSize": 1000,
        "marketCap": 54963000,
        "fiftyTwoWeekLow": 1.11,
        "fiftyTwoWeekHigh": 4.56,
        "priceToSalesTrailing12Months": 152.675,
        "fiftyDayAverage": 1.9452,
        "twoHundredDayAverage": 1.80965,
        "trailingAnnualDividendRate": 0,
        "trailingAnnualDividendYield": 0,
        "currency": "USD",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "coinMarketCapLink": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "4Q2021",
                    "actual": -0.31,
                    "estimate": -0.01
                },
                {
                    "date": "1Q2022",
                    "actual": -0.64,
                    "estimate": -0.41
                },
                {
                    "date": "2Q2022",
                    "actual": -0.17,
                    "estimate": -0.57
                },
                {
                    "date": "3Q2022",
                    "actual": -0.31,
                    "estimate": -0.68
                }
            ],
            "currentQuarterEstimate": -0.37,
            "currentQuarterEstimateDate": "4Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1677622680,
                1678141080
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 0,
                    "earnings": -21280891
                },
                {
                    "date": 2019,
                    "revenue": 0,
                    "earnings": -29417969
                },
                {
                    "date": 2020,
                    "revenue": 0,
                    "earnings": -22885449
                },
                {
                    "date": 2021,
                    "revenue": 1260000,
                    "earnings": -15373993
                }
            ],
            "quarterly": [
                {
                    "date": "4Q2021",
                    "revenue": 360000,
                    "earnings": -4420643
                },
                {
                    "date": "1Q2022",
                    "revenue": 0,
                    "earnings": -9179004
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": -2667036
                },
                {
                    "date": "3Q2022",
                    "revenue": 0,
                    "earnings": -5006945
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1677622680,
                1678141080
            ],
            "earningsAverage": -0.37,
            "earningsLow": -0.42,
            "earningsHigh": -0.34
        },
        "dividendDate": "2017-09-21T00:00:00.000Z"
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-02-02T14:06:36.000Z",
                "firm": "EF Hutton",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-06-25T15:22:01.000Z",
                "firm": "Needham",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2019-05-23T12:00:40.000Z",
                "firm": "Wedbush",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-12-20T14:16:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-08-17T18:04:58.000Z",
                "firm": "Raymond James",
                "toGrade": "Strong Buy",
                "fromGrade": "Outperform",
                "action": "up"
            },
            {
                "epochGradeDate": "2018-06-29T12:21:01.000Z",
                "firm": "Raymond James",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-12-20T12:03:32.000Z",
                "firm": "H.C. Wainwright",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": 0,
        "postMarketChange": 0,
        "postMarketTime": "2023-01-07T00:51:20.000Z",
        "postMarketPrice": 2.79,
        "postMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": -0.007117431,
        "regularMarketChange": -0.01999998,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 2.79,
        "regularMarketDayHigh": 2.885,
        "regularMarketDayLow": 2.76,
        "regularMarketVolume": 276759,
        "averageDailyVolume10Day": 991580,
        "averageDailyVolume3Month": 478380,
        "regularMarketPreviousClose": 2.81,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 2.8,
        "exchange": "NCM",
        "exchangeName": "NasdaqCM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ACER",
        "underlyingSymbol": null,
        "shortName": "Acer Therapeutics Inc.",
        "longName": "Acer Therapeutics Inc.",
        "currency": "USD",
        "quoteSourceName": "Nasdaq Real Time Price",
        "currencySymbol": "$",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "marketCap": 54963000
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": 45870432,
        "forwardPE": -4.5737705,
        "profitMargins": 0,
        "floatShares": 11260951,
        "sharesOutstanding": 19700000,
        "sharesShort": 657787,
        "sharesShortPriorMonth": 55482,
        "sharesShortPreviousMonthDate": 1668470400,
        "dateShortInterest": 1671062400,
        "sharesPercentSharesOut": 0.0337,
        "heldPercentInsiders": 0.18386,
        "heldPercentInstitutions": 0.26096,
        "shortRatio": 0.91,
        "shortPercentOfFloat": 0.044899996,
        "beta": 1.202586,
        "impliedSharesOutstanding": 0,
        "category": null,
        "bookValue": -0.746,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-09-30T00:00:00.000Z",
        "netIncomeToCommon": -21273628,
        "trailingEps": -1.393,
        "forwardEps": -0.61,
        "lastSplitFactor": "96:1000",
        "lastSplitDate": "2017-09-21T00:00:00.000Z",
        "enterpriseToRevenue": 127.418,
        "enterpriseToEbitda": -1.936,
        "52WeekChange": 0.22907484,
        "SandP52WeekChange": -0.16598755
    },
    "summaryProfile": {
        "address1": "One Gateway Center",
        "address2": "Suite 351 300 Washington Street",
        "city": "Newton",
        "state": "MA",
        "zip": "02458",
        "country": "United States",
        "phone": "844 902 6100",
        "website": "https://www.acertx.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.",
        "fullTimeEmployees": 41,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 2.79,
        "targetHighPrice": 12,
        "targetLowPrice": 7,
        "targetMeanPrice": 9.67,
        "targetMedianPrice": 10,
        "recommendationMean": 2,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 3,
        "totalCash": 6377923,
        "totalCashPerShare": 0.39,
        "ebitda": -23698394,
        "totalDebt": 8367076,
        "quickRatio": 0.307,
        "currentRatio": 0.351,
        "totalRevenue": 360000,
        "revenuePerShare": 0.024,
        "returnOnAssets": -0.62065,
        "grossProfits": 1260000,
        "freeCashflow": -13972397,
        "operatingCashflow": -23373906,
        "grossMargins": 1,
        "ebitdaMargins": 0,
        "operatingMargins": -66.030174,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}